Related Experiment Video
Updated: Jun 8, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
2-Aryl benzimidazoles: human SCD1-specific stearoyl coenzyme-A desaturase inhibitors
David A Powell1, Yeeman Ramtohul, Marie-Eve Lebrun
1Merck Frosst Centre for Therapeutic Research, 16711 Trans Canada Highway, Kirkland, Québec, Canada H9H 3L1. david_powell2@merck.com
Abstract:
A series of potent, benzimidazole-based SCD inhibitors which demonstrate selectivity for the hSCD1 enzyme over the hSCD5 isoform are described. The compounds possess suitable cellular activity and pharmacokinetic properties which render them capable of inhibiting liver SCD activity in a mouse pharmacodynamic assay. These 2-aryl benzimidazoles may serve as valuable tools for studying selective hSCD1-inhibition.
Related Concept Videos
Directing and Steric Effects in Disubstituted Benzene Derivatives
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Reduction of Benzene to Cyclohexane: Catalytic Hydrogenation
Drugs for Treatment of Ulcerative Colitis in IBD
